85
ECP 2014 ·
London
Poster Presentations
a
Sunday
Sunday, 31 Aug
PS-03
121
Androgen receptor expression as prognos-
tic factor in ER positive breast cancer
A. Marcell Szasz,
Hungary
A.-M. Tokes, L. Madaras, J. Kulka, G. Cserni
122
Selection of patients for OncotypeDx test-
ing in breast cancer in the UK
Emad Rakha,
United Kingdom
123
Adenoid cystic carcinoma of the breast:
Report of three cases and literature review
Helena Fuentes Vaamonde,
Spain
M. T. Gonzalez Serrano, M. Centeno Haro,
J. Salvatierra Cuenca, M. Medina Pérez
124
Molecular classification of breast cancer
and its clinicopathological correlations: A
retrospective cohort study
Dimitra Koumoundourou,
Greece
I. Nikolatou, E. Mpota, P. Ravazoula
125
Significance of the topographic expression
of the phosphorylated translational factor
eIF2A at serine 51 in invasive breast carci-
nomas
Lydia Nakopoulou,
Greece
I. Theohari, C. Patsis, A. Koromilas,
I. Giannopoulou, P. Alexandrou,
A. Keramopoulos
126
A lobular carcinoma metastatic to the
stomach: Case report and literature review
Panagiota Ravazoula,
Greece
H. Geropoulou, I. Nikolatou,
D. Koumoundourou
127
Collagen fibre patterns in breast cancer
Anna M. Bofin,
Norway
A. Brabrand, I. Kariuki, M. J. Engstrøm,
O. A. Haugen, L. A. Dyrnes, B. O. Åsvold,
M. B. Lilledahl
128
Intratumoural heterogeneity in breast can-
cer: A HER2 based case study
Michael Gandy,
United Kingdom
T. O´Grady, D. Allen, J. Starczynski,
M. Falzon, E. Kay
129
A case of male breast carcinoma leading to
diagnosis of neurofibromatosis type 1
Christos Poulios,
Greece
T. Koletsa, V. Gourvas, K. Chatzopoulos,
V. Papadopoulos, G. Karagiannopoulou,
P. Hytiroglou, I. Kostopoulos
130
Mammary Myofibroblastoma: A review of
5 cases with immunohistochemical fea-
tures
Maria del Rosario Taco,
Spain
C. Nienow, T. Soler, F. Climent, A. Petit,
A. Guma, M. Campos
131
Correlation of morphological aspects and
immunohistochemical prognostic factors
in breast cancer
Florica Staniceanu,
Romania
E. Gramada, C. Popp, A. Stoica, A. Evsei,
G. Halcu, A. Stan, S. Dutulescu, S. Zurac
132
Clinicopathological analyse of patients
with triple negative breast cancer
Esra Canan Kelten,
Turkey
C. Boyaci, U. R. Gursu, S. Aksoy,
D. Can Trabulus, D. Karacetin, S. Sirin
133
Evaluation of BCL2 and cyclin D1, as pre-
dictive and prognostic factors in locally
advanced and inflammatory breast cancer
treated with neoadjuvant chemotherapy
Amal Kouchkar,
Algeria
L. Atif, S. Sami, N. Terki
135
Accuracy of preoperative diagnostic biopsy
in metaplastic breast cancer
Luis Pérez Casanova,
Spain
M. T. Soler, I. Català, A. Petit, F. Climent,
E. Mancebo, M. López, M. Terricabras,
L. Prieto, E. Condom
